Abdulrahman Saleh Al-Mulhim1. 1. Department of Surgery, Medical College, King Faisal University, P.O. Box 1164, Hofuf, Al-Hassa, 31982, Kingdom of Saudi Arabia. abdu3939@yahoo.com
Abstract
BACKGROUND: Laparoscopic splenectomy has become the standard of care for benign hematological disease affecting the spleen; its role in massive splenomegaly remains controversial. In this study, we evaluated the outcome of laparoscopic splenectomies in terms of spleen size in a group of 83 patients of benign hematological diseases. METHODS: From July 2003 to December 2009, 83 patients underwent laparoscopic splenectomy for various benign hematological diseases. The data were recorded and analyzed in a retrospective manner. The patients were divided in to two groups according to the spleen weight; group I < 2,000 g (n = 54) and group II > 2,000 g (n = 29). Age, sex, hematological condition, operative time, estimated blood loss, conversion to open surgery, splenic weight, length of hospital stay, time to liquid diet, and morbidity were all recorded. RESULTS: Laparoscopic splenectomy was completed in 79 patients (95.2 %). Operative time (p = 0.01) and estimated blood loss (p = 0.001) was more in group II. The length of hospital stay (p = 0.05) and the postoperative morbidity (p = 0.001) also were significantly more in the second group. There was no mortality. CONCLUSIONS: Laparoscopic splenectomy is possible and safe for massive splenomegaly in hematological disease (>2,000 g), but it needs longer operative time and hospital stay.
BACKGROUND: Laparoscopic splenectomy has become the standard of care for benign hematological disease affecting the spleen; its role in massive splenomegaly remains controversial. In this study, we evaluated the outcome of laparoscopic splenectomies in terms of spleen size in a group of 83 patients of benign hematological diseases. METHODS: From July 2003 to December 2009, 83 patients underwent laparoscopic splenectomy for various benign hematological diseases. The data were recorded and analyzed in a retrospective manner. The patients were divided in to two groups according to the spleen weight; group I < 2,000 g (n = 54) and group II > 2,000 g (n = 29). Age, sex, hematological condition, operative time, estimated blood loss, conversion to open surgery, splenic weight, length of hospital stay, time to liquid diet, and morbidity were all recorded. RESULTS: Laparoscopic splenectomy was completed in 79 patients (95.2 %). Operative time (p = 0.01) and estimated blood loss (p = 0.001) was more in group II. The length of hospital stay (p = 0.05) and the postoperative morbidity (p = 0.001) also were significantly more in the second group. There was no mortality. CONCLUSIONS: Laparoscopic splenectomy is possible and safe for massive splenomegaly in hematological disease (>2,000 g), but it needs longer operative time and hospital stay.
Authors: M A Padmos; G T Roberts; K Sackey; A Kulozik; S Bail; J S Morris; B E Serjeant; G R Serjeant Journal: Br J Haematol Date: 1991-09 Impact factor: 6.998
Authors: Carlos Rodriguez-Otero Luppi; Eduardo M Targarona Soler; Carmen Balague Ponz; Juan Pablo Pantoja Millán; Victor Turrado Rodriguez; Jose Luis Pallares Segura; Jesus Bollo Rodriguez; Manel Trias Folch Journal: World J Surg Date: 2017-02 Impact factor: 3.352
Authors: Dorota Radkowiak; Anna Zychowicz; Michał Wysocki; Anna Lasek; Piotr Major; Michał Pędziwiatr; Piotr Budzyński; Marcin Dembiński; Jadwiga Dworak; Andrzej Budzynski Journal: Wideochir Inne Tech Maloinwazyjne Date: 2018-05-30 Impact factor: 1.195
Authors: Reuben D Shin; Roger Lis; Nicholas R Levergood; David C Brooks; Brent T Shoji; Ali Tavakkoli Journal: Surg Endosc Date: 2018-08-27 Impact factor: 4.584